Rongjie Health (300247.SZ): The Anhui Securities Regulatory Bureau ordered corrective measures against the company

Zhitong Finance App News, Rongjie Health (300247.SZ) announced that on December 19, 2025, the company received the “Decision on Ordering Corrective Measures against Rongjie Health Technology Co., Ltd.” issued by the Anhui Regulatory Bureau of the China Securities Regulatory Commission. The decision indicated that the company had irregularities:

First, accounting is not standardized. The company's main product sales all recognized revenue according to the time of delivery, which was inconsistent with the revenue recognition policy disclosed in the annual report; the company did not resell the value-added balance of the subsidiary's investment real estate assessment at the consolidated financial statements level, causing the “investment real estate” category in the consolidated financial statements for the period 2022 to 2024 inflated by 2.2509 million yuan.

Second, the disclosure of information is inaccurate. There are many errors and omissions in the company's 2024 annual report and notes to the financial statements. The amount disclosed before and after “assets and liabilities measured at fair value” was inconsistent; the reduction in the original book value of “fixed assets - office and other equipment” was less than the cumulative depreciation reduction amount for the current period; the disclosure of “foreign currency monetary items” was inaccurate; and changes in the “other accounts receivable” combined accounting estimates were not disclosed in accordance with regulations.

Third, the use of funds raised is irregular, and the disclosure of fund-raising information is inaccurate.